NanoViricides Inc. (NNVC)

[anhba]

a pipeline of 6 major drug candidates on less than $50 million spent and you are calling that the "most expensive"? That is laughable as it has to be the LEAST expensive pipeline of major drug candidates ever assembled by a biotech drug discovery company.

As far as the slowest, wrong there as well. Development time for successful drugs frequently exceeds 10 yrs.

And no a shelf filing is just that, a filing not a "grab of another $50 million" or any other such transaction. A shelf filing merely authorizes them to raise money as and if needed. Nearly all preclincal biotechs have them in place. At least any prudent management has one in place.

The world's slowest and most expensive pre-clinical march toward a freakin' tox test continues.